These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10449456)

  • 1. Use of molecular assays in diagnosis and monitoring of cytomegalovirus disease following renal transplantation.
    Aitken C; Barrett-Muir W; Millar C; Templeton K; Thomas J; Sheridan F; Jeffries D; Yaqoob M; Breuer J
    J Clin Microbiol; 1999 Sep; 37(9):2804-7. PubMed ID: 10449456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CMV viral load measurements in whole blood and plasma--which is best following renal transplantation?
    Barrett-Muir W; Breuer J; Millar C; Thomas J; Jeffries D; Yaqoob M; Aitken C
    Transplantation; 2000 Jul; 70(1):116-9. PubMed ID: 10919585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative PCR in the diagnosis of CMV infection and in the monitoring of viral load during the antiviral treatment in renal transplant patients.
    Piiparinen H; Helanterä I; Lappalainen M; Suni J; Koskinen P; Grönhagen-Riska C; Lautenschlager I
    J Med Virol; 2005 Jul; 76(3):367-72. PubMed ID: 15902704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of two quantitative CMV PCR tests, Cobas Amplicor CMV Monitor and TaqMan assay, and pp65-antigenemia assay in the determination of viral loads from peripheral blood of organ transplant patients.
    Piiparinen H; Höckerstedt K; Grönhagen-Riska C; Lautenschlager I
    J Clin Virol; 2004 Jul; 30(3):258-66. PubMed ID: 15135746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the murex hybrid capture cytomegalovirus DNA assay versus plasma PCR and shell vial assay for diagnosis of human cytomegalovirus viremia in immunocompromised patients.
    Barrett-Muir WY; Aitken C; Templeton K; Raftery M; Kelsey SM; Breuer J
    J Clin Microbiol; 1998 Sep; 36(9):2554-6. PubMed ID: 9705391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the Murex Hybrid Capture CMV DNA (v2.0) assay and the pp65 CMV antigenemia test for the detection and quantitation of CMV in blood samples from immunocompromised patients.
    Schirm J; Kooistra A; van Son WJ; van der Bij W; Verschuuren E; Sprenger HG; Limburg PC; The TH
    J Clin Virol; 1999 Dec; 14(3):153-65. PubMed ID: 10614852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qualitative plasma PCR assay (AMPLICOR CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic stem cell transplantation.
    Solano C; Muñoz I; Gutiérrez A; Farga A; Prósper F; García-Conde J; Navarro D; Gimeno C
    J Clin Microbiol; 2001 Nov; 39(11):3938-41. PubMed ID: 11682510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of cytomegalovirus infection in kidney transplant recipients by a quantitative RNA-DNA hybrid capture assay for cytomegalovirus DNA in leukocytes.
    Rollag H; Sagedal S; Holter E; Degré M; Ariansen S; Nordal KP
    Eur J Clin Microbiol Infect Dis; 1998 Feb; 17(2):124-7. PubMed ID: 9629980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences between the quantitative antigenemia assay and the cobas amplicor monitor quantitative PCR assay for detecting CMV viraemia in bone marrow and solid organ transplant patients.
    Flexman J; Kay I; Fonte R; Herrmann R; Gabbay E; Palladino S
    J Med Virol; 2001 Jul; 64(3):275-82. PubMed ID: 11424115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two commercial methods for measurement of cytomegalovirus load in blood samples after renal transplantation.
    Tong CY; Cuevas LE; Williams H; Bakran A
    J Clin Microbiol; 2000 Mar; 38(3):1209-13. PubMed ID: 10699024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
    Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK
    Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of laboratory assays to predict cytomegalovirus disease in renal transplant recipients.
    Tong CY; Cuevas L; Williams H; Bakran A
    J Clin Microbiol; 1998 Sep; 36(9):2681-5. PubMed ID: 9705413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of cytomegalovirus (CMV) viral load by the hybrid capture assay allows for early detection of CMV disease in lung transplant recipients.
    Bhorade SM; Sandesara C; Garrity ER; Vigneswaran WT; Norwick L; Alkan S; Husain AN; McCabe MA; Yeldandi V
    J Heart Lung Transplant; 2001 Sep; 20(9):928-34. PubMed ID: 11557186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus DNA concentration in plasma predicts development of cytomegalovirus disease in kidney transplant recipients.
    Rollag H; Sagedal S; Kristiansen KI; Kvale D; Holter E; Degré M; Nordal KP
    Clin Microbiol Infect; 2002 Jul; 8(7):431-4. PubMed ID: 12199854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative quantitation of cytomegalovirus (CMV) DNA in solid organ transplant recipients with CMV infection by using two high-throughput automated systems.
    Razonable RR; Brown RA; Espy MJ; Rivero A; Kremers W; Wilson J; Groettum C; Smith TF; Paya CV
    J Clin Microbiol; 2001 Dec; 39(12):4472-6. PubMed ID: 11724864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the AMPLICOR cytomegalovirus test with specimens from human immunodeficiency virus-infected subjects.
    Boivin G; Handfield J; Toma E; Murray G; Lalonde R; Tevere VJ; Sun R; Bergeron MG
    J Clin Microbiol; 1998 Sep; 36(9):2509-13. PubMed ID: 9705384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of cytomegalovirus DNA levels with response to antiviral therapy in cardiac and renal allograft recipients.
    Toyoda M; Carlos JB; Galera OA; Galfayan K; Zhang X; Sun Z; Czer LS; Jordan SC
    Transplantation; 1997 Apr; 63(7):957-63. PubMed ID: 9112347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Establishment of a real-time PCR assay for simultaneously detecting human BKV and CMV DNA and its application in renal transplantation recipients].
    Zhang CW; Chen XQ; Bai YH; Pan XD; Wang SL; Cai Y; Xia P; Wu CZ; Chen BC
    Bing Du Xue Bao; 2013 Jun; 29(4):410-4. PubMed ID: 23895006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of cytomegalovirus (CMV) antigenemia assay, polymerase chain reaction, serology, and shell vial assay in the early diagnosis and monitoring of CMV infection after renal transplantation.
    Tanabe K; Tokumoto T; Ishikawa N; Koyama I; Takahashi K; Fuchinoue S; Kawai T; Koga S; Yagisawa T; Toma H; Ota K; Nakajima H
    Transplantation; 1997 Dec; 64(12):1721-5. PubMed ID: 9422409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of plasma polymerase chain reaction and pp65-antigenemia assay in the quantification of cytomegalovirus in liver and kidney transplant patients.
    Piiparinen H; Höckerstedt K; Grönhagen-Riska C; Lappalainen M; Suni J; Lautenschlager I
    J Clin Virol; 2001 Aug; 22(1):111-6. PubMed ID: 11418358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.